News
(100%) in the 180mg cohort achieved a clinical response Tryptase levels below the lower limit of quantification observed in ...
During a Community Case Forum event, Adil Daud, MD, discussed immunotherapy options for cutaneous squamous cell carcinoma.
The company has brought down the price range. It now starts at Rs 16.75 lakh (ex-showroom), making it more accessible to the ...
Corvus' soquelitinib shows promise in oncology & autoimmune fields, with Phase 3 PTCL data as a key catalyst. Click here to ...
In CORAL, 165 IPF patients were given one of three doses of nalbuphine ER to test its ability to reduce cough frequency after six weeks.
Taking too much magnesium can cause a range of side effects and in some cases can lead to life-threatening toxicity. Learn ...
China is weaponizing the export of rare earths and related magnets, which are critical components in automobiles, especially ...
The FDA has approved a new pill called Widaplik, which combines three drugs – telmisartan, amlodipine, and indapamide – to treat adults who have high blood pressure.
MG unveils pricing for its premium-brand IM electric vehicles, surprising some who were expecting premium prices.
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer ...
AUTOPOST on MSN3d
Tata’s $3B Gamble to Rule the Green Roads of IndiaTata Motors is gearing up for a major investment push, planning to inject up to 350 billion INR (about 3 billion USD) over ...
Given the probability of trial success and current valuation, we rate the ATYR stock 'Hold' as risk and reward appear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results